Verrica Pharmaceuticals Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:VRCA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.68 M-10.04 M9.69 M-4.59 M-9.16 M -14.11 M Cash from investing activities —0000 0 Cash from financing activities -4.06 M-4.16 M-3.98 M13.64 M-120 K 5.38 M Free cash flow -12.68 M-10.04 M9.69 M-4.59 M-9.16 M -14.11 M

News

Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

Neurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript

Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan

Verrica’s partner launches molluscum treatment in Japan

Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why

New Strong Buy Stocks for February 2nd

How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating

Verrica doses first patient in phase 3 trial for common wart treatment